Antibodies, Monoclonal, Humanized [CS] - M0556300

Pharmacologic Code	M0556300
Pharmacologic Name	Antibodies, Monoclonal, Humanized
Pharmacologic Uses	CD20-directed cytolytic antibody CD4-directed post-attachment HIV-1 inhibitor humanized monoclonal antibody fragment (Fab) programmed death receptor-1 (PD-1)-blocking antibody
Pharmacologic Concept	Chemical Structure - [CS]
Pharmacologic Concept Description	This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy.

The table contains 7 products whose active ingredient are classified under the same pharmacologic class Antibodies, Monoclonal, Humanized [CS].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0597-0197	Praxbind	Non-Proprietary Name: Idarucizumab	Injection	Intravenous	Boehringer Ingelheim Pharmaceuticals, Inc.	ACTIVE
	50242-150	Ocrevus	Non-Proprietary Name: Ocrelizumab	Injection	Intravenous	Genentech, Inc.	ACTIVE
	50242-554	Ocrevus Zunovo	Non-Proprietary Name: Ocrelizumab And Hyaluronidase	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-917	Tecentriq	Non-Proprietary Name: Atezolizumab	Injection, Solution	Intravenous	Genentech, Inc.	ACTIVE
	50242-918	Tecentriq	Non-Proprietary Name: Atezolizumab	Injection, Solution	Intravenous	Genentech, Inc.	ACTIVE
	50242-933	Tecentriq Hybreza	Non-Proprietary Name: Atezolizumab And Hyaluronidase-tqjs	Injection	Subcutaneous	Genentech, Inc.	ACTIVE
	62064-122	Trogarzo	Non-Proprietary Name: Ibalizumab	Injection, Solution	Intravenous	Theratechnologies Inc.	ACTIVE